These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9521382)

  • 1. Antenatal indomethacin--adverse fetal effects confirmed.
    Souter D; Harding J; McCowan L; O'Donnell C; McLeay E; Baxendale H
    Aust N Z J Obstet Gynaecol; 1998 Feb; 38(1):11-6. PubMed ID: 9521382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indomethacin tocolysis increases postnatal patent ductus arteriosus severity.
    Hammerman C; Glaser J; Kaplan M; Schimmel MS; Ferber B; Eidelman AI
    Pediatrics; 1998 Nov; 102(5):E56. PubMed ID: 9794986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal complications after the administration of indomethacin for preterm labor.
    Norton ME; Merrill J; Cooper BA; Kuller JA; Clyman RI
    N Engl J Med; 1993 Nov; 329(22):1602-7. PubMed ID: 8232428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of antenatal indomethacin on ductus arteriosus early closure and on adverse outcomes in preterm neonates.
    Doni D; Paterlini G; Locatelli A; Arnoldi S; Magri MC; Bernasconi D; Valsecchi MG; Tagliabue PE
    J Matern Fetal Neonatal Med; 2020 Feb; 33(4):645-650. PubMed ID: 29986620
    [No Abstract]   [Full Text] [Related]  

  • 5. Outcome of very low birth weight infants exposed to antenatal indomethacin for tocolysis.
    Doyle NM; Gardner MO; Wells L; Qualls C; Papile LA
    J Perinatol; 2005 May; 25(5):336-40. PubMed ID: 15861198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent indomethacin tocolysis is not associated with neonatal complications in preterm infants.
    Vermillion ST; Newman RB
    Am J Obstet Gynecol; 1999 Nov; 181(5 Pt 1):1083-6. PubMed ID: 10561622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re: The debate regarding the risks of tocolytic agents.
    Humphrey M; King G
    Aust N Z J Obstet Gynaecol; 1998 Aug; 38(3):357-8. PubMed ID: 9761179
    [No Abstract]   [Full Text] [Related]  

  • 8. Antenatal indomethacin tocolysis is associated with an increased need for surgical ligation of patent ductus arteriosus in preterm infants.
    Soraisham AS; Dalgleish S; Singhal N
    J Obstet Gynaecol Can; 2010 May; 32(5):435-442. PubMed ID: 20500951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between antenatal indomethacin as a tocolytic drug and neonatal outcomes: a retrospective cohort study.
    Rovers JFJ; Thomissen IJC; Janssen LCE; Lingius S; Wieland BV; Dieleman JP; Niemarkt HJ; van Runnard Heimel PJ
    J Matern Fetal Neonatal Med; 2021 Sep; 34(18):2945-2951. PubMed ID: 31597542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perinatal indomethacin treatment and neonatal complications in preterm infants.
    Ojala R; Ikonen S; Tammela O
    Eur J Pediatr; 2000 Mar; 159(3):153-5. PubMed ID: 10664225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metaanalysis of the effect of antenatal indomethacin on neonatal outcomes.
    Amin SB; Sinkin RA; Glantz JC
    Am J Obstet Gynecol; 2007 Nov; 197(5):486.e1-10. PubMed ID: 17980183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preterm delivery after indomethacin. A risk factor for neonatal complications?
    Gardner MO; Owen J; Skelly S; Hauth JC
    J Reprod Med; 1996 Dec; 41(12):903-6. PubMed ID: 8979204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neonatal outcome after exposure to indomethacin in utero: a retrospective case cohort study.
    Abbasi S; Gerdes JS; Sehdev HM; Samimi SS; Ludmir J
    Am J Obstet Gynecol; 2003 Sep; 189(3):782-5. PubMed ID: 14526313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral lesions in preterm infants after tocolytic indomethacin.
    Baerts W; Fetter WP; Hop WC; Wallenburg HC; Spritzer R; Sauer PJ
    Dev Med Child Neurol; 1990 Oct; 32(10):910-8. PubMed ID: 2257989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antenatal exposure to magnesium sulfate and the incidence of patent ductus arteriosus in extremely low birth weight infants.
    del moral T; Gonzalez-Quintero VH; Claure N; Vanbuskirk S; Bancalari E
    J Perinatol; 2007 Mar; 27(3):154-7. PubMed ID: 17314984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of maternal tocolysis on the incidence of severe periventricular/intraventricular haemorrhage in very low birthweight infants.
    Weintraub Z; Solovechick M; Reichman B; Rotschild A; Waisman D; Davkin O; Lusky A; Bental Y;
    Arch Dis Child Fetal Neonatal Ed; 2001 Jul; 85(1):F13-7. PubMed ID: 11420315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indomethacin prophylaxis or expectant treatment of patent ductus arteriosus in extremely low birth weight infants?
    Cordero L; Nankervis CA; Delooze D; Giannone PJ
    J Perinatol; 2007 Mar; 27(3):158-63. PubMed ID: 17251986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Umbilical artery pH may be a possible confounder for neonatal adverse outcomes in preterm infants exposed to antenatal magnesium.
    Shimada E; Ogawa M; Matsuda Y; Mitani M; Matsui H
    J Matern Fetal Neonatal Med; 2013 Feb; 26(3):270-4. PubMed ID: 23020646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antenatal magnesium sulfate and the postnatal response of the ductus arteriosus to indomethacin in extremely preterm neonates.
    Katayama Y; Minami H; Enomoto M; Takano T; Hayashi S; Lee YK
    J Perinatol; 2011 Jan; 31(1):21-4. PubMed ID: 20505743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antenatal exposure to indomethacin increases the risk of severe intraventricular hemorrhage, necrotizing enterocolitis, and periventricular leukomalacia: a systematic review with metaanalysis.
    Hammers AL; Sanchez-Ramos L; Kaunitz AM
    Am J Obstet Gynecol; 2015 Apr; 212(4):505.e1-13. PubMed ID: 25448524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.